Recently, a Chinese genomewide association study (GWAS) identified four autosomal single-nucleotide polymorphism (SNP) loci as being significantly associated with risk factors for nonobstructive azoospermia (NOA; P , 5 3 10
INTRODUCTION
Infertility is a major problem worldwide that affects approximately 10% of couples, and roughly half of these cases are due to male-factor etiology [1, 2] . The main cause of male infertility is spermatogenic failure such as nonobstructive azoospermia (NOA) and oligozoospermia. Deletions in the azoospermia factor (AZF) regions on the long arm of the Y chromosome, which are prevalent in 10%-15% of male infertility patients, result in spermatogenic failure and severely reduce sperm concentrations [3, 4] . Polymorphisms in certain genes, such as the deleted-in-azoospermia-like (DAZL) [5] , androgen receptor (AR) [6] [7] [8] [9] , estrogen receptor (ER)a [10] [11] [12] , 5-methylenetetrahydrofolate reductase (MTHFR) [13] [14] [15] , and ADP-ribosyltransferase 3 (ART3) [16, 17] genes, have been reported to be associated with male infertility. However, studies of genetic associations frequently produce inconsistent results among different populations. For example, the T54A polymorphism in the DAZL gene was found to be associated with NOA in Taiwanese populations [5] but not in Italian [18] , Caucasian [19] , Japanese [20] , or Indian populations [21] . In addition, between-study differences have been observed in the associations between CAG repeat number polymorphisms in the AR gene and male infertility, and some studies have even reported significant associations [9, [22] [23] [24] [25] , whereas others obtained nonsignificant results [26] [27] [28] ).
Recently, a genomewide association study (GWAS) conducted on Chinese men indicated that common variants located near the PRMT6 (rs12097821 at 1p13.3), PEX10 (rs2477686 at 1p36.32), and SOX5 genes (rs10842262 at 12p12.1) were associated with NOA (rs12097821, OR ¼ 1.25; rs2477686, OR ¼ 1.39; and rs10842262, OR ¼ 1.23). Single-nucleotide polymorphism (SNP) rs6080550 at 20p13 (SIRPA-AIRPG) also exhibited a significant association (OR ¼ 1.27) with NOA in a combined analysis, although the association was not replicated in the second stage of validation [29] . To increase our understanding of the genetic risk factors for male infertility, we conducted a replication study to assess whether the four SNPs are associated with NOA in two distinct Japanese cohorts.
MATERIALS AND METHODS

Subjects
This study was performed at two research institutions in Japan. All participants provided informed consent. The patients and controls were recruited by multiple centers spread across mainland Japan, and all participants were of Japanese ethnicity.
Tokushima University sample (replication 1). In total, 72 NOA patients (33.1 6 5.5 yr; mean 6 SD) and 734 fertile controls (31.2 6 4.8 yr; mean 6 SD) were enrolled in the first part of our study. All 72 NOA patients were consecutively infertile and visited the Department of Urology, St. Mariana University Hospital, Kanagawa Prefecture, Japan. Semen analysis was performed in accordance with the World Health Organization (WHO) Laboratory Manual for the Examination of Human Semen [30] . NOA patients were diagnosed on the basis of semen analysis (absence of sperm in ejaculate), serum hormone levels, and the results of physical examinations. We excluded patients with any known cause of infertility (i.e., obstructive azoospermia, varicocele, cryptorchidism, hypogonadotropic hypogonadism, karyotype abnormalities, or Y chromosome microdeletions at the DYZ3, USP9Y, DBY, RBM, DAX, and DYZ1 loci). In addition, among the partners of pregnant women who attended obstetric clinics in four cities in Japan (Sapporo, Kanazawa, Osaka, and Fukuoka), 734 fertile men (sperm count . 20 3 10 6 /ml) were recruited [31] . Genomic DNA was extracted from the peripheral blood samples of subjects by using a QIAamp DNA blood kit (Qiagen, Tokyo, Japan). This study was approved by the ethics committees of the University of Tokushima and St. Marianna Medical University.
Tokai University sample (replication 2). The samples obtained by Okada et al. [16] were used in this part of the study. Briefly, 425 NOA patients were recruited from Niigata University, Tachikawa Hospital, and St. Mother's Hospital, and 441 fertile men were recruited from Niigata University to serve as fertile controls. Genomic DNA was prepared from white blood cell samples using DNeasy (Qiagen) or saliva samples via phenol/chloroform extraction. This study was approved by the ethics committees of Niigata University, Tachikawa Hospital, St. Mother's Hospital, and Tokai University.
Genotyping
Replication 1. The rs12097821, rs2477686, and rs10842262 SNPs were detected by the restriction fragment length polymorphism (RFLP)-PCR method using the following primer sets: rs12097821, 5
0 -GCAGTTGTATACTTATG CAC-3 0 (forward) and 5 0 -CAGAGAGTTTTAGATTGCCT-3 0 (reverse); rs2477686, 5 0 -GCAGTGTTCGTCCTGCAATC-3 0 (forward) and 5 0 -TGCTAGCAGCATCCACAGTC-3 0 (reverse); and rs10842262, 5 0 -GGCCCA GAAAGACAAATACT-3 0 (forward) and 5 0 -ATTGTTATCTCCAGCCATAC-3 0 (reverse). DNA from each subject was amplified using Taq DNA polymerase (Promega, Tokyo, Japan) under the appropriate amplification conditions. The resulting PCR products were then digested using the following restriction enzymes: rs12097821, AluI (New England Biolabs Japan Inc., Tokyo, Japan); rs2477686, XspI; and rs10842262, XspI (both from Takara Bio Inc., Otsu, Japan). The digested products were separated by electrophoresis on 2.5% agarose gel. The following fragment sizes were used for allele identification on gels: rs12097821, 24 þ 170 bp (G-allele) and 24 þ 70 þ 100 bp (T-allele); rs2477686, 87 þ 216 bp (C-allele) and 303 bp (G-allele); and rs10842262, 382 bp (C-allele) and 200 þ 182 bp (G-allele). The rs6080550 SNP was genotyped using TaqMan probes (C__30304328_10; Applied Biosystems, Tokyo, Japan) and the AB7500 real-time PCR system (Applied Biosystems).
Replication 2. TaqMan probes were used to genotype rs12097821 (C_3 190 51 67_ 10 ), r s2 477 68 6 (C_ 197 50 65_ 10) , r s1 084 226 2 (C_31383398_10), and rs6080550 (C__30304328_10).
Statistical Analysis
Hardy-Weinberg equilibrium (HWE) was assessed in control samples by using the Pearson chi-square test for genotypes. Per-allele odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated under the log-additive model using logistic regression analysis. Meta-analysis was performed by combining the ORs obtained from two Japanese cohorts using the fixed-effects model. The restricted maximum-likelihood procedure was employed to estimate the between-study heterogeneity variance. Based on this estimate, Cochran Q and I 2 statistics were calculated. All statistical analyses were performed using the R statistical environment (http://www.R-project.org) v2.14.2, specifically the R-package metafor (http://www.wvbauer.com/). P , 0.05 was considered statistically significant.
RESULTS
We genotyped four SNPs (rs12097821, rs2477686, rs10842262, and rs6080550) among 490 NOA patients and 1167 fertile controls from two distinct Japanese cohorts (replications 1 and 2). The allele and genotype frequencies of the four SNPs analyzed in each cohort are shown in Table 1 . The missing genotyping rates for the SNPs were not very high (highest rate, 3.7% for rs6080550 in replication 2), and the genotypes of all four SNPs were in HWE in the fertile controls of both cohorts (P . 0.05).
None of the four SNPs was significantly associated with NOA in either cohort. However, three of the four SNPs (rs12097821, rs2477686, and rs10842262) displayed associations in the same direction (per-allele ORs . 1) in both cohorts as previously reported in the GWAS [29] (Table 1) . To assess the strength of the association between each of the SNPs and the risk of NOA in the Japanese population, we performed a meta-analysis of the two independent replication studies. When combining the results of the two studies, we did not detect any significant between-cohort heterogeneity in any of the per-TABLE 1. Replication and meta-analysis of the SNP reported to be associated with NOA risk in a previous GWAS (Hu et al., 2012 [29] (Table 1) . However, all but one of the SNPs displayed the same trends as detected in the previous Chinese study, and the summary ORs were not statistically different between the previous Chinese GWAS and the present study.
DISCUSSION
A recent GWAS found that autosomal polymorphisms at three loci were associated with NOA in Chinese men [29] . In the present study, we performed two independent replication analyses of the four SNPs (rs12097821 at 1p13.3, rs2477686 at 1p36.32, rs10842262 at 12p12.1, and rs6080550 at 20p13) that were most strongly associated with NOA in the previous Chinese GWAS (P , 5 3 10 À8 ) [29] to assess the reported associations in the Japanese population. As the sample size of each cohort was not very large, we conducted a meta-analysis of the two cohorts by using a total of 490 NOA patients and 1167 fertile controls. In the meta-analysis, none of the four SNPs displayed a significant association with the risk of NOA in the Japanese population; however, three of four SNPs (rs12097821, rs2477686, and rs10842262) exhibited associations in the same direction as observed in the previous Chinese GWAS. The statistical power of meta-analysis for the detection of significant associations, involving the examined SNPs at the per-allele OR and risk allele frequencies reported in the original GWAS paper, was less than 80%. Therefore, insufficient statistical power may explain why no significant associations between the SNPs and NOA were detected in both Japanese cohorts. Moreover, meta-analysis determined that the SNP rs6080550 at 20p13 displayed an association in the opposite direction (combined OR ¼ 0.96) compared with that detected in the Chinese GWAS. It is worth noting that Hu et al. [29] cautiously reported this SNP as a susceptibility locus for NOA because of the borderline significance (P ¼ 0.1) of its association with NOA in the second stage of validation, which involved 766 NOA cases and 1995 controls, including a Shanghai cohort with no replication (P ¼ 0.783).
To date, there have been three other GWAS reports regarding male fertility and infertility. A pilot GWAS in Caucasians (92 cases and 80 controls) showed that 20 SNPs (P , 10
À5
) were significantly associated with azoospermia or oligozoospermia [32] . Recently, a GWAS involving NOA patients and fertile controls in Han Chinese performed by another Chinese research group showed that variants within the human leukocyte antigen (HLA) region were associated with NOA risks (HLA-DRA [rs3129878], P ¼ 3.70 3 10 À16 , OR ¼ 1.37; C6orf10 and BTNL2 [rs498422], P ¼ 2.43 3 10
À12
, OR ¼ 1.42) [33] . In addition, a GWAS in a Hutterite population in the United States indicated that 41 SNPs were significantly correlated with family size or birth rate (P , 1 3 10 À4 ). Of these SNPs, the following were found to be associated with sperm concentration or total sperm count in ethnically diverse men from Chicago: rs7867029 in the phosphoserine aminotransferase 1 gene (PSAT1), rs12870438 in the epithelial stromal interaction 1 gene (EPSTI1), rs7174015 in the ubiquitin specific peptidase 8 gene (USP8), and rs724078, which is located downstream of the ubiquitin D gene (UBD) [34] . However, none of these studies suggested the involvement of the four SNPs analyzed in the present study in the etiology of NOA or in spermatogenic failure. In general, the effect size of a disease risk factor is overestimated in association studies, in which it is first recognized as a risk factor. This overestimation, which is known as the ''winner's curse,'' can lead to subsequent validation studies failing to replicate the original result [35, 36] . Therefore, the actual effect sizes of the four SNPs at 1p13.3, 1p36.32, 12p12.1, and 20p13 may be smaller than those reported in the original GWAS. The nonsignificant associations detected in the present study may also be attributed to false positives that were obtained in the original GWAS or genetic differences in NOA susceptibility between Chinese and Japanese populations, although there are no marked differences in the distributions of linkage disequilibrium structures around the four SNPs between the HapMap-CHB and HapMap-JPT populations (Supplemental Figs. S1, S2, S3, and S4; available online at www.biolreprod. org). Further replication studies with larger sample sizes in Japanese and other populations, including Chinese subjects, evaluating the four SNPs examined in the present study are required to establish the genetic risk factors for NOA.
